Your Good Partner in Biology Research

【文獻(xiàn)精選】實(shí)驗(yàn)太難?CUSABIO產(chǎn)品為您科研助力!

日期:2019-12-09 16:38:58

 

\

 

武漢華美生物工程有限公司成立于2007年12月,是一家集科研、生產(chǎn)、銷售為一體的生物高新技術(shù)企業(yè)。并形成了以CUSABIO為品牌的ELISA試劑盒、蛋白、抗體等多種優(yōu)質(zhì)產(chǎn)品,遠(yuǎn)銷歐美日德等九十多個(gè)國(guó)家。

 


我們非常欣喜地看到華美的產(chǎn)品被越來(lái)越多的國(guó)際知名科研院所的科學(xué)家們所使用,并助力推進(jìn)他們的科學(xué)研究,同時(shí)也被SCI頂級(jí)文獻(xiàn)的審稿人認(rèn)可。

2019年11月(2019.11.1-11.30)部分產(chǎn)品引用文獻(xiàn)整理如下,查看華美所有產(chǎn)品引用文獻(xiàn),請(qǐng)點(diǎn)擊閱讀原文或以下網(wǎng)址:

http://m.cstxtech.com/technical_show_4.html


ELISA試劑盒
0
1

BRIT J PHARMACOL(IF:6.583)

標(biāo)題:

Rosiglitazone alleviates α-naphthylisothiocyanate-induced intrahepatic cholestasis in mice-The role of circulating 15d-PGJ2 and Nogo

明星產(chǎn)品:

Human Reticulon-4(RTN4) ELISA kit

(CSB-EL020572HU)

檢測(cè)范圍:46.88 pg/mL-3000 pg/mL

靈敏度:11.75 pg/mL

\

 

0
2

Cancer Letters(IF:6.508)

標(biāo)題:

Immune activation, immune senescence and levels of Epstein Barr Virus in kidney transplant patients: Impact of mTOR inhibitors

明星產(chǎn)品:

人脂多糖/內(nèi)毒素(LPS)ELISA Kit

(CSB-E09945h)

檢測(cè)范圍:6.25 pg/mL-400 pg/mL

靈敏度: 1.56 pg/mL

\

 

0
3
 

CELL DEATH DIS(IF:5.959)

標(biāo)題:

Mitochondrial 3243A > G mutation confers pro-atherogenic and pro-inflammatory properties in MELAS iPS derived endothelial cells

明星產(chǎn)品:

人氧化低密度脂蛋白抗體(OLAb)ELISA Kit
(CSB-E08797h)

檢測(cè)范圍:47 μU/mL-3000 μU/mL

靈敏度:11.75 μU/mL

\

 

0
4

Cells(IF:5.656)

標(biāo)題:

Phosphatidylethanolamine-Binding Protein 1 Ameliorates Ischemia-Induced Inflammation and Neuronal Damage in the Rabbit Spinal Cord

明星產(chǎn)品:

兔子髓過(guò)氧化物酶(MPO)ELISA Kit

(CSB-E13689Rb)

檢測(cè)范圍:1.25 ng/mL-20 ng/mL

靈敏度: 1.25 pg/mL

 

 

抗  體
0
1

FREE RADICAL BIO MED(IF:5.657)

標(biāo)題:

The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia

明星產(chǎn)品:

TXNRD2 Antibody 

(CSB-PA885675ESR2HU)

種屬反應(yīng)性:Human, Mouse

應(yīng)用范圍:ELISA, WB, IHC

\

 

NFKBIA Antibody

(CSB-PA010535)

種屬反應(yīng)性:Human, Mouse, Rat

應(yīng)用范圍:ELISA, WB, IHC, IF

 

Phospho-NFKBIA (S32/S36) Antibody

(CSB-PA000559)

種屬反應(yīng)性:Human, Mouse, Rat, Monkey

應(yīng)用范圍:ELISA, WB, IHC, IF

 

CASP3 Antibody 

(CSB-PA001231)

種屬反應(yīng)性:Human, Mouse, Rat

應(yīng)用范圍:ELISA, WB, IHCIF

\

 

0
2

The Faseb Journal(IF:5.391)

標(biāo)題:

ATP synthase inhibitory factor 1 (IF1), a novel myokine, regulates glucose metabolism by AMPK and Akt dual pathways

明星產(chǎn)品:

INS Antibody 

(CSB-PA12089A0Rb)

種屬反應(yīng)性:Human

應(yīng)用范圍:ELISA, IHC

\

 

0
3

Electrochimica Acta(IF:5.383)

標(biāo)題:

Stable thin films of human P53 antigen on gold surface for the detection of tumour associated anti-P53 autoantibodies

明星產(chǎn)品:

TP53 Monoclonal Antibody 

(CSB-MA0240771A0m)

種屬反應(yīng)性:Human

應(yīng)用范圍:ELISA, WB, IHC

\

 

0
4

 

J CELL MOL MED(IF:4.658)

標(biāo)題:

Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway

明星產(chǎn)品:

COL1A1 Antibody

(CSB-PA005727OA01HU)

種屬反應(yīng)性:Human

應(yīng)用范圍:ELISA, IF

\

 

蛋  白

 

0
1

 

Electrochimica Acta(IF:5.383)

標(biāo)題:

Stable thin films of human P53 antigen on gold surface for the detection of tumour associated anti-P53 autoantibodies

明星產(chǎn)品:

Recombinant Human Cellular tumor antigen p53(TP53) 

(CSB-EP024077HU)

蛋白來(lái)源:E.coli

蛋白標(biāo)簽:N-terminal 6xHis-SUMO-tagged

 

\

 

0
2

 

J AM HEART ASSOC(IF: 4.66)

標(biāo)題:

Pigment Epithelium-Derived Factor Increases Native Collateral Blood Flow to Improve Cardiac Function and Induce Ventricular Remodeling After Acute Myocardial Infarction

明星產(chǎn)品:

Recombinant Rat Alpha-2 antiplasmin(Serpinf1) 

(CSB-EP021084RA)

蛋白來(lái)源:E.coli

蛋白標(biāo)簽:N-terminal GST-tagged

\

 

注:由于SCI各期刊被Google收錄的效率和頻率不一樣,很可能本月會(huì)收到一些較早時(shí)間發(fā)表的文章。此處文章整理,只為方便科研人員了解CUSABIO產(chǎn)品。

 

 

—END—

——華美生物·讓科研變得有溫度!——


●●●
直擊諾獎(jiǎng)|『氧感應(yīng)機(jī)制』榮獲2019年諾貝爾生理或醫(yī)學(xué)獎(jiǎng)
《Nature》:和想象完全不一樣?博士生、蠻難的!!!
關(guān)注|2019年最新SCI影響因子(JCR2018)已公布(附完整版下載)
必讀|影響因子排名第一神刊CA-2018全球癌癥最新統(tǒng)計(jì)數(shù)據(jù)
必讀|神刊CA(IF=244.59)再次發(fā)文-2019美國(guó)癌癥數(shù)據(jù)速讀
必讀|WHO發(fā)布最新預(yù)防癡呆癥指南-如何早預(yù)防?
解讀|這個(gè)殺手有點(diǎn)冷-肝炎專題
重磅|獵殺癌細(xì)胞基因名單發(fā)布!揭秘628個(gè)抗癌藥物靶點(diǎn)
解讀|美國(guó)癌癥研究協(xié)會(huì)(AACR)2019年度癌癥進(jìn)展報(bào)告出爐
關(guān)注|細(xì)胞免疫治療-CAR-T細(xì)胞療法
資源|腫瘤數(shù)據(jù)庫(kù)匯總收藏
資源|七大模式生物數(shù)據(jù)庫(kù)

資源|基礎(chǔ)研究數(shù)據(jù)庫(kù)匯總 

匯總|細(xì)胞器標(biāo)志物通宵整理

精品推介|新興治療靶點(diǎn)BCMA

精品推介|EGFR最新研究進(jìn)展及藥物發(fā)展現(xiàn)狀